Pharmacogenomics

Pharmacogenomics is the study of how genes affect a person’s response to drugs. This is a new field and combines pharmacology and genomics to develop effective and safe medications and doses that will be designed according to a person’s genetic organization. The field of pharmacogenomics is still in its early stage. Its use is currently quite limited, but new approaches are under study in clinical trials. It deals with the influence of acquired and inherited genetic variation on drug response in patients by correlating gene expression or single-nucleotide polymorphisms with pharmacokinetics and pharmacodynamics.

 

  • Genome
  • Drug response
  • Epigenetics
  • Genotyping
  • Genome sequencing
  • Polypharmacy
  • Drug labeling

Related Conference of Pharmacogenomics

August 18-19, 2025

40th World Congress on Pharmacology and Therapeutics

Valencia, Spain
September 19-20, 2025

18th World Drug Delivery Summit

Paris, France
September 22-23, 2025

Pharma Biotech Expo

Toronto, Canada
September 23-24, 2025

10th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
November 13-14, 2025

21st International Conference on Pharmaceutical Chemistry

Aix-en-Provence, France
November 20-21, 2025

21st Annual Congress on Pharmacology and Toxicology

Paris, France
November 27-28, 2025

4th World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 27-28, 2025

4th World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 27-28, 2025

13th International Conference on Clinical Trials

Amsterdam, Netherlands
February 23-24, 2026

3rd World Congress on Biologics and Biosimilars

London, Aland Islands
April 27-28, 2026

9th European Biopharma Congress

Paris, Aland Islands

Pharmacogenomics Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in